NOVA MSC BERHAD 08 February 2024 1. Details of Corporate Proposal Involve issuance of new type/class of securities ? No Types of corporate proposal Conversion of Preference Shares Details of corporate proposal Conversion of Irredeemable Convertible Preference Shares No. of shares issued under this corporate proposal 499,000 Issue price per share ($$) Malaysian Ringgit (MYR) 0.0400 Par Value($$)…
2 Feb 2024 – We are thrilled to unveil a groundbreaking partnership: EyRIS and Pliny are joining forces through a Memorandum of Understanding (MOU), paving the way for a strategic collaboration that promises to revolutionize the delivery of eye care. Through seamless integration with ophthalmic modalities, Pliny provides centralized storage and a unified view of all patient diagnostic scans in…
NOVA MSC BERHAD 30 January 2024 Type Announcement Subject OTHERS Description NOVACITYNETS, a wholly owned subsidiary of NOVA MSC, received a letter of award for a RM35.4 million contract for automation project Further to the announcement made by the Company on 26 January 2024, we would like to update that the expected commencement date of the Contract will be…
30 Jan 2024 – Announced in 2022, SATUSEHAT is Ministry of Health Indonesia’s initiative to build a digital eco-system to facilitate data exchange and service efficiency for care providers and government through the seamless integration of healthcare facilities and IT systems they are running. SATUSEHAT also serves a medium for the public to access their own Electronic Medical Record (EMR)…
NOVA MSC BERHAD 26 January 2024 Type Announcement Subject OTHERS Description NOVACITYNETS, a wholly owned subsidiary of NOVA MSC, received a letter of award for a RM35.4 million contract for automation project The Board of Directors of Nova MSC Berhad is pleased to announce that the Company’s wholly-owned subsidiary novaCITYNETS Pte Ltd (“NCN”) has received a letter of award…
Jan 2024 – EyRIS extends our heartiest congratulations to our founder Prof. Tien Yin Wong for his recent appointment to the NEJM AI Editorial Board. NEJM AI, a new monthly journal from NEJM Group, is the first publication to engage both clinical and technology innovators in applying the rigorous research and publishing standards of the New England Journal of Medicine…
26 Jan 2024 – Nova MSC Berhad’s (“Nova MSC” or “the Company”), a leading provider of innovative technology solutions, is excited to announce that its wholly-owned subsidiary, novaCITYNETS Pte Ltd (“NCN”), has been awarded a significant RM35.4 million contract by Sys-Mac Automation Engineering Pte Ltd (“Sys-Mac”) in Singapore. Under this contract, NCN will be responsible for the supply, delivery, installation,…
23 Jan 2024 – We are thrilled to announce the successful conclusion of our collaborative agreement with iCare, marking a significant milestone in the world of eye care. The partnership will result in both companies working together to seamlessly integrate SELENA+ our AI for retinal diseases with iCare’s proprietary platform, ILLUME. ILLUME, developed by iCare, is a cutting-edge platform meticulously…
22 Jan 2024 – EyRIS is thrilled to announce that we have officially appointed One Health, a subsidiary of PureHealth, as our exclusive distributor within the United Arab Emirates (UAE). Recognized as the largest integrated healthcare provider in the UAE, PureHealth’s collaboration with EyRIS signifies the initiation of a transformative alliance poised to redefine healthcare standards across both public and…
Jan 2024 – A wonderful piece of news to kick-start the new year. A couple of years back, the EU Parliament legislated the transitional provisions from Medical Devices Directive (MDD) to Medical Devices Regulation (MDR). The new standard took into consideration the need for more stringent technical documentation, implementation of unique device identification (UDI) for better traceability and recall and…